A model‐based approach to investigating the relationship between glucose‐insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes-Reference-Cited by-同舟云学术

A model‐based approach to investigating the relationship between glucose‐insulin dynamics and dapagliflozin treatment effect in patients with type 2 diabetes

Published:2021-01-25 Issue:4 Volume:23 Page:991-1000
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Shah Millie¹^ORCID,Stolbov Leonid²^ORCID,Yakovleva Tatiana²^ORCID,Tang Weifeng¹^ORCID,Sokolov Victor²^ORCID,Penland Robert C.³^ORCID,Boulton David¹^ORCID,Parkinson Joanna⁴^ORCID

Affiliation:

1. Clinical Pharmacology and Quantitative Pharmacology Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gaithersburg Maryland

2. M&S Decisions Moscow Russia

3. Clinical Pharmacology and Quantitative Pharmacology Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Waltham Massachusetts

4. Clinical Pharmacology and Quantitative Pharmacology Clinical Pharmacology and Safety Sciences, R&D, AstraZeneca Gothenburg Sweden

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/dom.14305

Reference41 articles.

1. Dapagliflozin, a Novel, Selective SGLT2 Inhibitor, Improved Glycemic Control Over 2 Weeks in Patients With Type 2 Diabetes Mellitus

2. Sodium-Glucose Cotransport Inhibition With Dapagliflozin in Type 2 Diabetes

3. Dapagliflozin, a Novel SGLT2 Inhibitor, Induces Dose-Dependent Glucosuria in Healthy Subjects

4. Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test

5. Skeletal Muscle Insulin Resistance Is the Primary Defect in Type 2 Diabetes

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dapagliflozin: A new hope for the therapeutic treatment of type 2 diabetes mellitus;European Journal of Medicinal Chemistry Reports;2024-08

2. Applying quantitative and systems pharmacology to drug development and beyond: An introduction to clinical pharmacologists;Indian Journal of Pharmacology;2024-07

3. A mechanistic modeling platform of SGLT2 inhibition: Implications for type 1 diabetes;CPT: Pharmacometrics & Systems Pharmacology;2023-03-16

4. Algorithms and methodological challenges in the development and application of quantitative systems pharmacology models: a case study in type 2 diabetes;Russian Journal of Numerical Analysis and Mathematical Modelling;2022-11-01

5. Analysis of pharmacological data using mathematical modeling approach;Proceedings of the International Conference "Mathematical Biology and Bioinformatics";2022-10-27